Medicare Enrolled

Dr. David Lanfear, M.D.

Cardiovascular Disease · Detroit, MI
Consulting-driven
HENRY FORD HEALTH SYSTEM, Detroit, MI 48202
3139169106
In practice since 2006 (19 years)
NPI: 1184792632 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lanfear from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lanfear? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lanfear

Dr. David Lanfear is a cardiovascular disease specialist in Detroit, MI, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Lanfear received a total of $81,038 from 21 pharmaceutical and/or device companies across 195 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lanfear is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice $81,038 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$81,038
Total received (2018-2024)
Avg $11,577/year across 7 years
Top 4% in MI for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
21
Companies
195
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$65,988 (81.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$8,158 (10.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,891 (8.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$5,515
2023
$11,351
2022
$9,996
2021
$8,982
2020
$13,601
2019
$16,449
2018
$15,142

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Illumina, Inc.
$4,800
Eli Lilly and Company
$357
Novartis Pharmaceuticals Corporation
$114
Siemens Medical Solutions USA, Inc.
$89
CVRx, Inc.
$85
Abbott Laboratories
$70
Top 3 companies account for 95.6% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$28,669
Janssen Scientific Affairs, LLC
$12,875
Otsuka Pharmaceutical Development & Commercialization, Inc.
$9,292
Abbott Laboratories
$8,132
Janssen Pharmaceuticals, Inc
$5,224
Illumina, Inc.
$4,800
AstraZeneca AB
$4,699
ABIOMED
$4,005
AstraZeneca Pharmaceuticals LP
$1,355
Novartis Pharmaceuticals Corporation
$686
Eli Lilly and Company
$357
Procyrion, Inc.
$238
NOVARTIS PHARMACEUTICALS CORPORATION
$140
Novo Nordisk Inc
$124
Roche Diagnostics Corporation
$109
Siemens Medical Solutions USA, Inc.
$89
CVRx, Inc.
$85
HeartFlow, Inc.
$66
ENDOTRONIX, INC.
$50
Lilly USA, LLC
$33
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$9
Top 3 companies account for 62.7% of all-time payments
Associated products mentioned in payments ›
AORTIX SYSTEM · BRILINTA · Barostim Neo System · CD cobas Reagents · CORDELLA PULOMONARY ARTERY PRESSURE SENSOR · CardioMEMS HF System · Circulatory Support · Confirm Rx · Corlanor · ENTRESTO · EVENITY · EnSite X · FARXIGA · FFRct · Genetic Disease Research · Genetic Disease Testing · HeartMate · HeartMate 3 Left Ventricular Assist Device · HeartMate 3 Left Ventricular Dev · HeartMate Touch · INVOKANA · Impella · LEQVIO · LOKELMA · LifeVest · Oncology Testing · Repatha · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (81%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 4% for cardiovascular disease in MI.

Looking for a cardiovascular disease specialist in Detroit?
Compare cardiologists in the Detroit area by procedure volume, costs, and industry payment transparency.
Browse cardiologists nearby

Geographic Context

Cardiologists within 10 mi
314
Per 100K population
17.7
County median income
$59,521
Nearest hospital
HENRY FORD HEALTH HOSPITAL
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lanfear is a cardiovascular disease specialist, with consulting-driven industry engagement in the top 4% of MI peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Lanfear receive payments from pharmaceutical companies?
Yes. Dr. Lanfear received a total of $81,038 from 21 companies across 195 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Lanfear) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Cardiologists in Detroit
Browse cardiologists in Detroit ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in MI
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in MI
Which MI cardiologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Janssen Scientific Affairs, LLC Payments to Doctors
See all physicians who received payments from Janssen Scientific Affairs, LLC.
By company
Otsuka Pharmaceutical Development & Commercialization, Inc. Payments to Doctors
See all physicians who received payments from Otsuka Pharmaceutical Development & Commercialization, Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →